US Patent Issued to Enveric Biosciences Canada on July 15 for "Substituted n-propylamine fused heterocyclic mescaline derivatives" (Canadian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,885, issued on July 15, was assigned to Enveric Biosciences Canada Inc. (Calgary, Canada).

"Substituted n-propylamine fused heterocyclic mescaline derivatives" was invented by Kaveh Matinkhoo (Calgary, Canada), David James Press (Calgary, Canada), Glynnis Elizabeth Jensen (Calgary, Canada), Ye Cai (Edmonton, Canada), Jillian M. Hagel (Calgary, Canada) and Peter J. Facchini (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are novel fused mescaline derivative compounds, notably substituted N-propylamine fused heterocyclic mescaline derivatives, including substituted N-propylamine fused dioxolane mescaline derivatives, and phar...